Nicholas Vita is the Co-Founder, Vice Chairman and Chief Executive Officer of Columbia Care, Inc. (Ticker Symbol: CCHW.NE), one of the largest global medical cannabis companies operating throughout the United States and Europe.
Nicholas has over 25 years of experience serving in corporate leadership roles, investing capital, structuring and funding public/private partnerships and providing strategic advisory services to Fortune 500 companies throughout the U.S., Europe, Asia and Latin America. Prior to Columbia Care, Nicholas was a Partner and served as the Chairman of the Investment Committee at Apelles Investment Management, LLC, a private investment management company focused on the healthcare and privatized military infrastructure sectors. Before Apelles, Nicholas was a General Partner, member of the Investment Committee, and the Portfolio Manager for the Healthcare Sector at ARX Investment Management, a multi-billion dollar global credit hedge fund. Previously, he worked in the Investment Banking Division at Goldman, Sachs & Co. Inc., as an Analyst, Associate and Vice President in the Healthcare Department focused on Mergers, Raid Defense and Corporate Finance. He is a graduate of Columbia College, Columbia University where he was a member of the Men’s Varsity Heavyweight Crew Team (1993 Columbia University “Crew of the Year”, 1st place – Novice, Eastern Sprints National Rowing Championship) and President of Saint Anthony Hall. In 2018 he was awarded a Tribeca Film Festival Disruptive Innovation Award for his efforts to combat the opioid crisis as CEO of Columbia Care. Nicholas has served as a guest lecturer at a number of leading universities, serves on several corporate and philanthropic advisory boards including GenNext (NY), Success Academy, Deerfield Club of New York, NY State Industrial Hemp Working Group (Appointed by the Governor) and US Attorney General (Eastern District, NY) Counterterrorism Working Group (“Disruption and Early Engagement”) and is a Knight of the Sovereign Military Hospitaller Order of Saint John of Jerusalem, of Rhodes and of Malta. In addition, he was awarded the 2019 Top 100 Corporate Chieftains and 2018 Health & Life Sciences 50 Irish-American Innovators by Irish America Magazine as well as being named as a 2018 CEO of the Year by CEO Monthly Magazine.